Hypoxia confers protection against apoptosis via PI3K/Akt and ERK pathways in lung cancer cells

SM Lee, CT Lee, YW Kim, SK Han, YS Shim, CG Yoo - Cancer letters, 2006 - Elsevier
SM Lee, CT Lee, YW Kim, SK Han, YS Shim, CG Yoo
Cancer letters, 2006Elsevier
Hypoxia confers protection against apoptosis in cancer cells, and this hypoxia-induced
resistance to apoptosis has been suggested to be associated with genetic and adaptive
changes. However, it is not clear whether survival signals, such as the PI3K/Akt and ERK
pathways are involved. We investigated the roles of these pathways in hypoxia-induced
protection against apoptosis in lung cancer cells. Treatment of cells with either ultraviolet
(UV) or etoposide induced apoptosis time-dependently in A549 and NCI-H157 cells …
Hypoxia confers protection against apoptosis in cancer cells, and this hypoxia-induced resistance to apoptosis has been suggested to be associated with genetic and adaptive changes. However, it is not clear whether survival signals, such as the PI3K/Akt and ERK pathways are involved. We investigated the roles of these pathways in hypoxia-induced protection against apoptosis in lung cancer cells. Treatment of cells with either ultraviolet (UV) or etoposide induced apoptosis time-dependently in A549 and NCI-H157 cells. However, though hypoxia alone neither induced apoptosis nor reduced cell survival, it suppressed the apoptosis induced by UV or etoposide. Moreover, hypoxia activated the PI3K/Akt and ERK pathways, and blocking the activation of either pathway reversed resistance to UV- and etoposide-induced apoptosis in response to hypoxia. These results suggest that hypoxia confers resistance to UV- or etoposide-mediated apoptosis in lung cancer cells via the activations of the PI3K/Akt and the ERK pathways.
Elsevier